Markers of cardiac dysfunction in cognitive impairment and dementia S Hilal, YL Chai, MK Ikram, S Elangovan, TB Yeow, X Xin, JY Chong, ... Medicine 94 (1), 2015 | 87 | 2015 |
Association between subclinical cardiac biomarkers and clinically manifest cardiac diseases with cortical cerebral microinfarcts S Hilal, YL Chai, S Van Veluw, MA Shaik, MK Ikram, ... JAMA neurology 74 (4), 403-410, 2017 | 78 | 2017 |
Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration YL Chai, JR Chong, J Weng, D Howlett, A Halsey, JH Lee, J Attems, ... Brain pathology 29 (1), 63-74, 2019 | 71 | 2019 |
Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease Y Zhu, YL Chai, S Hilal, MK Ikram, N Venketasubramanian, BS Wong, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 7, 41-47, 2017 | 68 | 2017 |
Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment YL Chai, JR Chong, AR Raquib, X Xu, S Hilal, N Venketasubramanian, ... Scientific reports 11 (1), 1-11, 2021 | 64 | 2021 |
APOE and cortical superficial siderosis in CAA: Meta-analysis and potential mechanisms A Charidimou, HI Zonneveld, S Shams, K Kantarci, A Shoamanesh, ... Neurology 93 (4), e358-e371, 2019 | 64 | 2019 |
Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia YL Chai, S Hilal, JPC Chong, YX Ng, OW Liew, X Xu, MK Ikram, ... Medicine 95 (33), 2016 | 54 | 2016 |
Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer’s disease and vascular cognitive impairment XY Chua, YL Chai, WS Chew, JR Chong, HL Ang, P Xiang, K Camara, ... Alzheimer's research & therapy 12 (1), 1-12, 2020 | 36 | 2020 |
An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias A Datta, YL Chai, JM Tan, JH Lee, PT Francis, CP Chen, SK Sze, MKP Lai Molecular brain 10 (1), 1-13, 2017 | 32 | 2017 |
Apolipoprotein ɛ4 is associated with dementia and cognitive impairment predominantly due to Alzheimer’s disease and not with vascular cognitive impairment: a Singapore-based cohort YL Chai, HKH Yeo, J Wang, S Hilal, MK Ikram, N Venketasubramanian, ... Journal of Alzheimer's Disease 51 (4), 1111-1118, 2016 | 32 | 2016 |
Increased transforming growth factor β2 in the neocortex of Alzheimer’s disease and dementia with lewy bodies is correlated with disease severity and soluble Aβ 42 load JR Chong, YL Chai, JH Lee, D Howlett, J Attems, CG Ballard, D Aarsland, ... Journal of Alzheimer's Disease 56 (1), 157-166, 2017 | 31 | 2017 |
Mitochondrial translocase of the outer membrane alterations may underlie dysfunctional oxidative phosphorylation in Alzheimer’s disease YL Chai, H Xing, JR Chong, PT Francis, CG Ballard, CP Chen, MKP Lai Journal of Alzheimer's Disease 61 (2), 793-801, 2018 | 29 | 2018 |
Serum hepatocyte growth factor is associated with small vessel disease in Alzheimer’s dementia Y Zhu, S Hilal, YL Chai, MK Ikram, N Venketasubramanian, CP Chen, ... Frontiers in aging neuroscience 10, 8, 2018 | 27 | 2018 |
Autoantibodies to GM1 and GQ1bα are not Biological Markers of Alzheimer's Disease Y Miura, K Miyaji, YL Chai, CLH Chen, MKP Lai, N Yuki Journal of Alzheimer's Disease 42 (4), 1165-1169, 2014 | 13 | 2014 |
Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment: A case-control study YL Chai, JR Chong, AR Raquib, X Xu, S Hilal, N Venketasubramanian, ... | 1 | 2020 |
Brain free‐water increases mediate the association of blood cardiovascular biomarkers with longitudinal cognitive decline in prodromal and clinical dementia: Neuroimaging/multi … F Ji, O Pasternak, YL Chai, S Liu, MQW Ong, BY Tan, AM Richards, ... Alzheimer's & Dementia 16, e044477, 2020 | | 2020 |
INCREASED PSER129 α-SYNUCLEIN IS ASSOCIATED WITH SYNAPTIC DEFICITS IN DEMENTIA WITH LEWY BODIES: 2017 Abstract Supplement MKP Lai, H Xing, JR Chong, YL Chai, D Aarsland, PT Francis, CP Chen Alzheimer's & Dementia 13 (7, Supplement), P461, 2017 | | 2017 |